---
title: "Addressing Immune Imprinting with Updated LP.8.1 mRNA Boosters"
id: "news-news-lancet-infectious-diseases-1c14dfaa19504314c855c85d"
canonical_url: "https://medichelpline.com/news/news-news-lancet-infectious-diseases-1c14dfaa19504314c855c85d"
content_type: "medical_news_article"
category: "Infectious Disease"
source_name: "The Lancet Infectious Diseases"
source_url: "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00050-2/fulltext?rss=yes"
published_at: "2026-02-09T23:30:01.000Z"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Addressing Immune Imprinting with Updated LP.8.1 mRNA Boosters
## Metadata & Source Attribution
- **Canonical URL:** https://medichelpline.com/news/news-news-lancet-infectious-diseases-1c14dfaa19504314c855c85d
- **Category:** [Infectious Disease](https://medichelpline.com/news/infectious-disease.md)
- **Reporting Source:** The Lancet Infectious Diseases
- **Original Source URL:** [Read Original Article](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00050-2/fulltext?rss=yes)
- **Published At:** 2026-02-09T23:30:01.000Z
## Executive Summary & Key Highlights
In response to emerging COVID-19 variants, the LP.8.1 mRNA booster has been designed to enhance immunity against circulating strains, overcoming immune imprinting.
## In-Depth Reporting & Editorial Analysis
During the summer of 2025, the SARS-CoV-2 JN.1 sublineage became the dominant strain, accompanied by resistant variants, including XFG, LP.8.1, and NB.1.8.1. To combat this, COVID-19 mRNA boosters were updated for the 2025–2026 season to specifically target the spike protein of LP.8.1. Previous boosters, especially the WA1/2020+BA.5 bivalent version, had notably boosted immunity towards the ancestral strain, a situation referred to as immune imprinting. This study assessed whether the new LP.8.1 mRNA booster would enhance responses to currently circulating strains.
## Navigation
- [← Back to Infectious Disease News](https://medichelpline.com/news/infectious-disease.md)
- [← All Medical News Categories](https://medichelpline.com/news.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.